Roger Penske sells a third of Indianapolis Motor Speedway and IndyCar to Fox
The sale was described as a strategic investment and partnership designed to launch new growth for IndyCar and it includes a multi-year contract extension for Fox Sports' media rights deal with the open-wheel series. Fox Sports is in its first season broadcasting IndyCar.
Penske Entertainment expects the sale of part of the company to spearhead innovative and industry-leading racing and entertainment events, heightened digital strategy and immersive content focus, as well as enhanced promotion and star-building opportunities for IndyCar drivers.
'This partnership is built on long-standing trust and a shared vision for the future,' Roger Penske said in a statement. 'Fox sees the incredible potential across our sport and wants to play an active role in building our growth trajectory.
'Lachlan Murdoch and his team, starting with Eric Shanks, are committed to our success and will bring incredible energy and innovation to IndyCar.'
Shanks is an Indiana native who grew up attending the Indianapolis 500 and has an affinity for IndyCar racing. He desperately wanted to add IndyCar to Fox Sports' properties and snagged the TV deal away from NBC Sports ahead of this season.
All races are broadcast on Fox making IndyCar the only series in the United States that does not air any of its events on cable. This year's Indianapolis 500 on Fox averaged 7.01 million viewers — a 41% increase over last year and a 17-year high.
This season, IndyCar is averaging a 31% increase in viewership year-over-year.
'We're thrilled to join the IndyCar ownership group at such a pivotal time for the sport,' said Shanks, CEO & Executive Producer, Fox Sports. 'IndyCar represents everything we value in live sports — passionate fans, iconic venues, elite competition and year-round storytelling potential.
'This investment underscores our commitment to motorsports and our belief in IndyCar's continued growth on and off the track. We're excited to help elevate the sport to new heights across all platforms.'
The sale to Fox gives some clarity to the succession plan for Penske, who bought IndyCar and the speedway ahead of the 2020 season. He has long declined to discuss his succession plans although sons Roger Jr. and Greg are involved in the racing entities of the Penske Entertainment.
The sale of a portion of Penske Entertainment creates more seats at its leadership table moving forward, but Penske has remained steadfast in his determination that IndyCar and Indianapolis Motor Speedway will be generational assets for his family.
Penske, who is 88, still runs the day-to-day operations of all of his businesses, which includes racing teams in NASCAR, IndyCar, and IMSA and WEC sports car racing, as well as his billion-dollar transportation empire at Penske Corp.
Penske Automotive also owns multiple car dealerships and Penske is one of the largest BMW dealers in the United States. His race teams, the transportation business and his dealerships are not part of the Fox transaction.
___
AP auto racing: https://apnews.com/hub/auto-racing
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory
We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on Valueinvesting subreddit by bluespacecolombo. In this article, we will summarize the bulls' thesis on RARE. Ultragenyx Pharmaceutical Inc.'s share was trading at $27.61 as of July 28th. A scientist in a laboratory coat looking into a microscope at human bone regeneration samples. Ultragenyx Pharmaceutical (RARE) has seen its share price halve in just two weeks, largely due to a halted trial and an FDA rejection, but the market appears to have overreacted. The company's Phase 3 trial for setrusumab, a potential blockbuster therapy for a rare bone disease, failed to meet an early 'stop-for-efficacy' milestone, yet the study remains on track, with safety intact and final results expected in late 2025 under less stringent endpoints. Meanwhile, the FDA issued a complete response letter for another gene therapy candidate, citing manufacturing issues rather than safety or efficacy concerns. The program remains viable, with a resubmission expected once production adjustments are made. Despite these setbacks, Ultragenyx continues to generate meaningful revenue, posting $139 million in Q1 and guiding for over $640 million in 2025, and maintains a robust cash position of around $560 million, with management projecting lower cash burn. Beyond setrusumab, the company's pipeline is well diversified, featuring DTX401, a gene therapy for glycogen storage disease that met Phase 3 goals and is slated for FDA submission this year, as well as an advanced Angelman syndrome program in Phase 3. None of the recent regulatory or clinical updates involved failures of safety or efficacy, leaving the scientific foundation of the pipeline intact. Analysts' average price targets remain near $100, implying a potential threefold upside from the current ~$26 level. With solid fundamentals, multiple near-term catalysts, and a temporarily depressed valuation, Ultragenyx represents a compelling contrarian opportunity as panic-driven selling unwinds. Previously we covered a bullish thesis on Capricor Therapeutics, Inc. (CAPR) by androidmj in March 2025, which highlighted the upcoming FDA decision on Deramiocel, strong financial backing, and significant upside on approval. The company's stock has depreciated about 46.32% since then as the thesis has yet to play out. The thesis still stands given CAPR's cash runway and de-risked catalyst. bluespacecolombo shares a similar view on the biotech space but emphasizes Ultragenyx's diversified pipeline, overreaction-driven selloff, and near-term catalysts. Ultragenyx Pharmaceutical Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 55 hedge fund portfolios held RARE at the end of the first quarter which was 57 in the previous quarter. While we acknowledge the potential of RARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
24 minutes ago
- Yahoo
Yankees swept, Red Sox sweep & a weekend recap
Subscribe to Baseball Bar-B-Cast Apple Podcasts | Spotify | YouTube The post-trade deadline MLB season got off to an inauspicious start for the New York Yankees as they flew down to Miami and got swept by the Marlins. That was the first time in franchise history that the Marlins swept the Yankees. Miami is now back to .500 while the Yankees have fallen to third in the AL East. Although New York still owns one of the coveted Wild Card spots, is Aaron Boone's seat starting to get a bit warmer? Jake and Jordan discuss this, what is going on with the Yankees and if they still look like they can be a postseason contender. Feeling the exact opposite of the Yankees right now is their bitter rival, the Boston Red Sox. Boston spent the weekend cleaning up Fenway as they swept the Houston Astros. The Red Sox now sit atop of the AL Wild Card race and just three games back in the AL East. The Milwaukee Brewers were the third and final sweep of the weekend as they took care of the Washington Nationals. How are both the Brewers and Red Sox looking as they inch closer to the postseason? Is Jacob Misiorowski going to the IL as big of a deal as it may seem? The guys dive into both of these series. There was a baseball game at a Nascar stadium this weekend. The Cincinnati Reds played the Atlanta Braves at Bristol Motor Speedway. The game finished up on Sunday after Saturday saw it get rained out in the first inning. Although the pomp and circumstance, complete with a Home Run Car, was dampened by the rain, the spectacle was still a sight to behold as the Braves took down the Reds. Jake and Jordan discuss this unique event and run through every other series from the weekend. Start your week off right at the Baseball Bar-B-Cast. (2:01) - Marlins sweep Yankees (22:11) - Boston & Milwaukee sweeps (35:24) - Speedway Classic (49:42) - Duran's debut in Philly (56:23) - Turbo Mode🖥️
Yahoo
24 minutes ago
- Yahoo
Tesla Offers Musk $30 Billion to Stay--With Strings Attached
Tesla (NASDAQ:TSLA) just handed CEO Elon Musk a massive new stock awardworth around $30 billiondesigned to keep him anchored at the helm while the company weathers legal battles and business headwinds. The package includes 96 million shares at a $23.34 exercise price, and it only kicks in if Musk stays in a senior leadership role for another two years. It's a stopgap move while the board appeals a court decision that voided his original 2018 compensation plan. That plan, once pegged at $56 billion, has become a flashpoint for investors and governance advocates alike. The interim award signals Tesla's intent to keep Musk focused during a volatile phase for the business. Tesla's board calls this a good faith gestureand timing matters. After a tough first half marked by declining sales, falling revenue, and a 25% YTD drop in share price, the company is leaning heavily on Musk's leadership to navigate what it describes as a critical inflection point. According to Wedbush analyst Dan Ives, the new agreement helps remove a lingering cloud over the stock and likely cements Musk's role for the foreseeable future. The board is also developing a longer-term pay structure, to be voted on at the November 6 shareholder meeting. But leadership retention isn't the only thing on the line. Musk's attention has been split across multiple venturesSpaceX, xAI, X Corp, Neuralink, The Boring Companyand his recent political entanglements haven't helped. The board acknowledges these distractions but says Musk remains central to Tesla's ability to attract and retain talent. Meanwhile, Tesla is trying to build momentum around its new robotaxi program, launched in Austin, which could be a long-term growth lever. Whether this compensation reset keeps Musk focused on Teslaor just buys timeis what investors will be watching next. This article first appeared on GuruFocus. Sign in to access your portfolio
